Trial Profile
An Open-label, Two-treatment, Two-period, Two-sequence, Crossover Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Fimasartan (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertension; Hypertriglyceridaemia; Low HDL cholesterol
- Focus Pharmacokinetics
- 14 Jul 2011 Results published in the Journal of Cardiovascular Pharmacology.
- 14 Oct 2009 New trial record